This inventor holds 1 USPTO granted patent. Top assignee: Rutgers, The State University of New Jersey. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Jaclynn A Meshanni: Innovator in Pulmonary Function Treatment
Introduction
Jaclynn A Meshanni is a notable inventor based in Hawthorne, NJ (US). She has made significant contributions to the field of pulmonary function treatment. Her innovative approach focuses on improving respiratory health through advanced methodologies.
Latest Patents
Jaclynn holds a patent for a method of treating reduced pulmonary function by administering an effective dose of a Farnesoid X Receptor (FXR) agonist, particularly obeticholic acid. This patent also includes an in vivo animal model of lung injury and altered functioning, which is useful for identifying compounds that can restore pulmonary function. She has 1 patent to her name.
Career Highlights
Jaclynn is affiliated with Rutgers, the State University of New Jersey, where she continues her research and development in pulmonary health. Her work is pivotal in advancing treatment options for individuals with compromised lung function.
Collaborations
Jaclynn collaborates with esteemed colleagues, including Debra L Laskin and Grace L Guo, who contribute to her research endeavors.
Conclusion
Jaclynn A Meshanni is a dedicated inventor whose work in pulmonary function treatment is making a significant impact in the medical field. Her innovative methods and collaborations are paving the way for improved respiratory health solutions.